Noble Corporation (NE)
NYSE: NE
· Real-Time Price · USD
28.34
-0.40 (-1.39%)
At close: Sep 03, 2025, 3:59 PM
27.83
-1.80%
Pre-market: Sep 04, 2025, 07:21 AM EDT
-1.39% (1D)
Bid | 28.25 |
Market Cap | 4.5B |
Revenue (ttm) | 2.6B |
Net Income (ttm) | 504.04M |
EPS (ttm) | 1.9 |
PE Ratio (ttm) | 14.92 |
Forward PE | 20.53 |
Analyst | Hold |
Ask | 28.79 |
Volume | 2,080,912 |
Avg. Volume (20D) | 2,017,061 |
Open | 28.45 |
Previous Close | 28.74 |
Day's Range | 28.25 - 29.09 |
52-Week Range | 17.40 - 37.99 |
Beta | 1.11 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Noble Corporation is scheduled to release its earnings on
Nov 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+2.08%
Noble shares are trading higher after the company ...
Unlock content with
Pro Subscription
4 months ago
+7%
Noble shares are trading higher after the company reported better-than-expected Q1 sales results.

1 day ago · proactiveinvestors.com
MustGrow Biologics' early TerraSante success signals market potential, Noble analysts sayNoble Capital Markets analysts have highlighted MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)'s growing commercial traction following the company's second quarter results. The analysts pointed to...

4 weeks ago · seekingalpha.com
Noble Corporation plc (NE) Q2 2025 Earnings Conference Call TranscriptNoble Corporation plc (NYSE:NE ) Q2 2025 Earnings Call August 6, 2025 9:00 AM ET Company Participants Ian MacPherson - Vice President of Investor Relations Richard B. Barker - Executive VP & CFO Rober...